RxDoctor Payments Data

Lindsey Cole, PA

Physician Assistant · High Point, NCNPI 1437913381

Payments from drug & device makers

$2,552in general payments, 2019–2025

Across 149 payments — averaging $17.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$725
  • Novo Nordisk$374
  • Lilly USA, LLC$222
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$180
  • Mayne Pharma Commercial LLC$145
  • Corcept Therapeutics$126
  • plus $781 from 20 others

What the payments were for

  • Food & beverage$2,552100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,552 in reported general payments places this provider in the 80th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$12,845
Medicare patients
46
Services billed
469

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide19$20,858
MounjaroTirzepatide16$18,055
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen152$7,064
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen138$5,211
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl26$2,701
Oxycodone Hcl80$1,159
Pregabalin42$956
Gabapentin33$611
Cyclobenzaprine Hcl41$410
Tizanidine Hcl39$390
Tramadol Hcl20$385
Omeprazole18$325
Fluticasone Propionate16$249
Baclofen14$238
Albuterol Sulfate HfaAlbuterol Sulfate12$215

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$374$20,85819 claims
Lilly USA, LLCMounjaro$222$18,05516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in High Point

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →